Long pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #51,001 to #51,050.
- (hist) Thoughts On Sand Casting Parts In Simple Step By Step Order [3,832 bytes]
- (hist) ZNF133 [3,832 bytes]
- (hist) PIGN (gene) [3,832 bytes]
- (hist) IMITREX injection clinical studies [3,832 bytes]
- (hist) WBR0209 [3,832 bytes]
- (hist) WBR0199 [3,832 bytes]
- (hist) Lymphadenopathy (patient information) [3,832 bytes]
- (hist) SLC7A2 [3,832 bytes]
- (hist) Acacia rigidula [3,832 bytes]
- (hist) Laryngeal prominence [3,832 bytes]
- (hist) Spatial dependence [3,832 bytes]
- (hist) Psychogenic disease [3,832 bytes]
- (hist) Oxeye daisy [3,832 bytes]
- (hist) Duct (anatomy) [3,832 bytes]
- (hist) Galanin-like peptide [3,831 bytes]
- (hist) Brucellosis primary prevention [3,831 bytes]
- (hist) Metatarsalphalangeal joint sprain [3,831 bytes]
- (hist) Rigshospitalet [3,831 bytes]
- (hist) Royan Institute [3,831 bytes]
- (hist) ZNF331 [3,830 bytes]
- (hist) SPOCK2 [3,830 bytes]
- (hist) Direct Xa inhibitor [3,830 bytes]
- (hist) WBR0800 [3,830 bytes]
- (hist) Menopause historical perspective [3,830 bytes]
- (hist) OR7C1 [3,830 bytes]
- (hist) Prometaphase [3,830 bytes]
- (hist) MRGPRX2 [3,830 bytes]
- (hist) Gaussian process [3,830 bytes]
- (hist) Dictamnus [3,830 bytes]
- (hist) Calcium tartrate [3,830 bytes]
- (hist) Ruthenocene [3,830 bytes]
- (hist) Salicylaldoxime [3,830 bytes]
- (hist) Interatrial septum [3,830 bytes]
- (hist) Paclitaxel (patient information) [3,830 bytes]
- (hist) Sexcord/ stromal ovarian tumors risk factors [3,829 bytes]
- (hist) MAP3K9 [3,829 bytes]
- (hist) FAM155A [3,829 bytes]
- (hist) Infectious colitis epidemiology and demographics [3,829 bytes]
- (hist) The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study [3,829 bytes]
- (hist) Upper gastrointestinal bleeding primary prevention [3,829 bytes]
- (hist) Esophageal cancer history and symptoms [3,829 bytes]
- (hist) The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy Suggest Revisions to the CLASS IIb Guidelines [3,829 bytes]
- (hist) The Living Guidelines: Antiplatelet Agents/Anticoagulants: Warfarin View the Current CLASS I Guidelines [3,829 bytes]
- (hist) The Living Guidelines: PCI after Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion Suggest Revisions to the CLASS I Guidelines [3,829 bytes]
- (hist) Mediastinum [3,829 bytes]
- (hist) M-Toluic acid [3,829 bytes]
- (hist) Penicillin G potassium microbiology [3,828 bytes]
- (hist) Creutzfeldt-Jakob disease future or investigational therapies [3,828 bytes]
- (hist) Parotitis causes [3,828 bytes]
- (hist) Obsessive-compulsive disorder other imaging findings [3,828 bytes]